DD222311A5 - Verfahren zur herstellung neuer flavanone und thioflavanone - Google Patents

Verfahren zur herstellung neuer flavanone und thioflavanone Download PDF

Info

Publication number
DD222311A5
DD222311A5 DD84266739A DD26673984A DD222311A5 DD 222311 A5 DD222311 A5 DD 222311A5 DD 84266739 A DD84266739 A DD 84266739A DD 26673984 A DD26673984 A DD 26673984A DD 222311 A5 DD222311 A5 DD 222311A5
Authority
DD
German Democratic Republic
Prior art keywords
substituted
phenyl
unsubstituted
formula
alkylamino
Prior art date
Application number
DD84266739A
Other languages
German (de)
English (en)
Inventor
Christian G Rimbault
Original Assignee
Zyma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zyma Sa filed Critical Zyma Sa
Publication of DD222311A5 publication Critical patent/DD222311A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06Benzothiopyrans; Hydrogenated benzothiopyrans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DD84266739A 1983-08-31 1984-08-29 Verfahren zur herstellung neuer flavanone und thioflavanone DD222311A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838323291A GB8323291D0 (en) 1983-08-31 1983-08-31 Flavanone and thioflavanone derivatives

Publications (1)

Publication Number Publication Date
DD222311A5 true DD222311A5 (de) 1985-05-15

Family

ID=10548079

Family Applications (1)

Application Number Title Priority Date Filing Date
DD84266739A DD222311A5 (de) 1983-08-31 1984-08-29 Verfahren zur herstellung neuer flavanone und thioflavanone

Country Status (20)

Country Link
US (1) US4885298A (el)
EP (1) EP0139614B1 (el)
JP (1) JPS60155176A (el)
AT (1) ATE55694T1 (el)
AU (1) AU580006B2 (el)
CA (1) CA1251213A (el)
DD (1) DD222311A5 (el)
DE (1) DE3483033D1 (el)
DK (1) DK415984A (el)
ES (1) ES8800191A1 (el)
FI (1) FI843362A (el)
GB (2) GB8323291D0 (el)
GR (1) GR80258B (el)
HU (1) HUT36817A (el)
IL (1) IL72775A (el)
NO (1) NO843453L (el)
NZ (1) NZ209393A (el)
PH (2) PH23456A (el)
PT (1) PT79144B (el)
ZA (1) ZA846785B (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3431534A1 (de) * 1984-08-28 1986-03-13 Merck Patent Gmbh, 6100 Darmstadt Flavanonderivate
ATE529418T1 (de) * 2003-06-20 2011-11-15 Pokka Corp Flavanonverbindung und deren verwendungen
KR100985103B1 (ko) * 2008-08-07 2010-10-05 덕성여자대학교 산학협력단 티오플라바논 유도체의 제조 방법
EP2423213B1 (en) * 2009-04-23 2014-01-08 Yang, Gengliang Preparation and use of novel antibiotic, anticancer compounds and derivatives thereof
CN110615784B (zh) * 2019-10-25 2022-10-25 南开大学 具有黄酮骨架的内酯类似物的合成及应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2727057A (en) * 1952-03-01 1955-12-13 Monsanto Chemicals Preparation of ethylene sulfonates
GB1250388A (el) * 1968-11-27 1971-10-20
US3678044A (en) * 1970-10-22 1972-07-18 Chevron Res Substituted flavanones
US3772243A (en) * 1970-10-26 1973-11-13 Chevron Res Polypropylene stabilized with substituted chalcones and flavanones
GB1522057A (en) * 1975-11-03 1978-08-23 Pfizer 9-hydroxydibenzo(b,d)pyrans and intermediates therefor
US4235913A (en) * 1977-06-07 1980-11-25 Pfizer Inc. 9-Hydroxyhexahydrodibeno[b,d]pyrans, 1-substituted-9-hydroxyhexahydrodibenzo]b,d]pyrans
US4162162A (en) * 1978-05-08 1979-07-24 E. I. Du Pont De Nemours And Company Derivatives of aryl ketones and p-dialkyl-aminoarylaldehydes as visible sensitizers of photopolymerizable compositions
US4228177A (en) * 1979-08-08 1980-10-14 E. R. Squibb & Sons, Inc. 2,3-Dihydro-3-(1H-imidazol-1-ylmethylene)-4H-1-benzothiopyran-4-ones
US4241069A (en) * 1979-09-04 1980-12-23 Miles Laboratories, Inc. 3-Methylene flavanones and 3-methylene chromanones
CH648030A5 (de) * 1980-12-15 1985-02-28 Sandoz Ag Benzopyran-allylaminderivate, verfahren zu ihrer herstellung und ihre verwendung.
GB8421801D0 (en) * 1984-08-29 1984-10-03 Unilever Plc Detergent composition

Also Published As

Publication number Publication date
DK415984A (da) 1985-03-01
GB2145718B (en) 1987-02-04
DE3483033D1 (de) 1990-09-27
GB8421776D0 (en) 1984-10-03
CA1251213A (en) 1989-03-14
ES535588A0 (es) 1987-11-01
IL72775A0 (en) 1984-11-30
EP0139614A3 (en) 1985-12-27
PT79144B (en) 1986-11-14
AU3257084A (en) 1985-03-07
US4885298A (en) 1989-12-05
IL72775A (en) 1988-11-15
ES8800191A1 (es) 1987-11-01
PH24450A (en) 1990-06-25
ZA846785B (en) 1985-04-24
ATE55694T1 (de) 1990-09-15
FI843362A (fi) 1985-03-01
GB8323291D0 (en) 1983-10-05
NO843453L (no) 1985-03-01
AU580006B2 (en) 1988-12-22
HUT36817A (en) 1985-10-28
NZ209393A (en) 1987-11-27
PH23456A (en) 1989-08-07
GB2145718A (en) 1985-04-03
PT79144A (en) 1984-09-01
JPS60155176A (ja) 1985-08-15
DK415984D0 (da) 1984-08-30
GR80258B (en) 1985-01-02
EP0139614A2 (en) 1985-05-02
FI843362A0 (fi) 1984-08-27
EP0139614B1 (en) 1990-08-22

Similar Documents

Publication Publication Date Title
DE60130256T2 (de) Naphthalinderivate, die sich an den ep4?rezeptor binden
DE60204718T2 (de) 3-substituierte oxindol beta 3 agonisten
DE69118388T2 (de) Substituierte bizyklische arylderivate mit selektiver leukotrien b4 antagonistischer wirkung
DE60203263T2 (de) Pyrazolderivate gegen tgf überexprimierung
DD300434A5 (de) Heterozyklische derivate
BR112019024376A2 (pt) composto de fórmula geral (i), ou sais farmaceuticamente aceitáveis destes, composição farmacêutica e uso dos compostos ou sais farmaceuticamente aceitáveis destes
EP1228059A1 (de) Neue cyclopropane als cgrp-antagonisten, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE69018876T2 (de) Pyridazinon-Derivate.
EP1611094B1 (de) Pyrazolverbindungen
DE3830060A1 (de) 2-phenylbenzimidazole - verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
DE69201302T2 (de) Therapeutische zusammenstellungen auf der basis von 1,2-dithiole-3-thionderivaten.
DE3343922A1 (de) Gewisse substituierte pyrazolochinoline, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen und ihre therapeutische anwendung
JP2021524504A (ja) チオフェン誘導体
DD222311A5 (de) Verfahren zur herstellung neuer flavanone und thioflavanone
JP2856548B2 (ja) チオナフタレン誘導体およびその製法並びにそれを含む抗アレルギー剤
DD210908A5 (de) Verfahren zur herstellung von ketenthioacetaten
AT371462B (de) Verfahren zur herstellung neuer benzopyranderivate und ihrer salze
DE69104481T2 (de) Imidazo[4,5-c]pyridine als paf antagonisten.
DE69030044T2 (de) Tetrazolessigsäurederivate mit Aldosereduktase inhibierender Wirkung
DD222025A5 (de) Verfahren zur herstellung neuer flavene oder thioflavene
DD249019A5 (de) Verfahren zur herstellung von tricyclischen verbindungen
DE3216843A1 (de) Thiomethylpyridin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE68916685T2 (de) Mevalonolactone vom Typ Pyrazolopyridin.
DD234008A5 (de) Flavene and thioflavene derivates, processes for their manufacture, pharmaceutical preparationsthat contain such compounds, and the use of the latter
SE444170B (sv) Nya 2-pyridyl- och 2-pyrimidylaminobensoesyror, forfarande for framstellning derav samt anvendning av foreningarna som aktiv komponent i terapeutiska kompositioner, speciellt som antiallergika

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee